Search

Your search keyword '"Receptors, Complement biosynthesis"' showing total 248 results

Search Constraints

Start Over You searched for: Descriptor "Receptors, Complement biosynthesis" Remove constraint Descriptor: "Receptors, Complement biosynthesis"
248 results on '"Receptors, Complement biosynthesis"'

Search Results

1. Interleukin-33 Amplifies Human Mast Cell Activities Induced by Complement Anaphylatoxins.

2. Complement peptide C3a receptor 1 promotes optic nerve degeneration in DBA/2J mice.

3. Myocardial expression of the anaphylatoxin receptor C3aR is associated with cardiac inflammation and prognosis in patients with non-ischaemic heart failure.

4. The Significance of VSIG4 Expression in Ovarian Cancer.

5. Soluble expression of disulfide-bonded C-type lectin like domain of human CD93 in the cytoplasm of Escherichia coli.

6. Let-7g-5p inhibits epithelial-mesenchymal transition consistent with reduction of glioma stem cell phenotypes by targeting VSIG4 in glioblastoma.

7. LL-37-induced host cell cytotoxicity depends on cellular expression of the globular C1q receptor (p33).

8. CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid Leukemia.

9. Expression and regulation of complement receptors by human natural killer cells.

10. VSIG4 expression on macrophages facilitates lung cancer development.

11. Tenocyte activation and regulation of complement factors in response to in vitro cell injury.

12. Modulation of retinal Müller cells by complement receptor C5aR.

13. Role of complement activation in obliterative bronchiolitis post-lung transplantation.

14. Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology.

15. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice.

16. Decreased expression of complement 3a receptor (C3aR) in human placentas from severe preeclamptic pregnancies.

17. Anaphylatoxin receptors and complement regulatory proteins in human articular and non-articular chondrocytes: interrelation with cytokines.

18. C5a and its receptors in human anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.

19. CD93: recent advances and implications in disease.

20. The epidermal growth factor-like domain of CD93 is a potent angiogenic factor.

21. Peri-implantitis fibroblasts respond to host immune factor C1q.

22. The complement inhibitors Crry and factor H are critical for preventing autologous complement activation on renal tubular epithelial cells.

23. Complement receptor 1 expression on mouse erythrocytes mediates clearance of Streptococcus pneumoniae by immune adherence.

24. CD93/AA4.1: a novel regulator of inflammation in murine focal cerebral ischemia.

25. Evidence that a C1q/C1qR system regulates monocyte-derived dendritic cell differentiation at the interface of innate and acquired immunity.

26. Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damage.

27. Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts.

28. Expression of AA4.1 marks lymphohematopoietic progenitors in early mouse development.

29. Mouse CD4+ CD25+ T regulatory cells are protected from autologous complement mediated injury by Crry and CD59.

30. Complement-dependent T-cell lymphopenia caused by thymocyte deletion of the membrane complement regulator Crry.

31. C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation.

32. Scrapie pathogenesis: the role of complement C1q in scrapie agent uptake by conventional dendritic cells.

33. Mast cell activation is characterized by upregulation of a functional anaphylatoxin C5a receptor.

34. Alteration in kidney glucose and amino acids are implicated in renal pathology in MRL/lpr mice.

35. Complement induction in spinal cord microglia results in anaphylatoxin C5a-mediated pain hypersensitivity.

36. Altered expression of Fcgamma and complement receptors on B cells in systemic lupus erythematosus.

37. High levels of complement C3a receptor in the glomeruli in lupus nephritis.

38. Decrease in CD93 (C1qRp) expression in a human monocyte-like cell line (U937) treated with various apoptosis-inducing chemical substances.

39. Mast cell-expressed complement receptor, not TLR2, is the main detector of zymosan in peritonitis.

40. Allorecognition in urochordates: identification of a highly variable complement receptor-like protein expressed in follicle cells of Ciona.

41. Complement components, regulators and receptors are produced by human monocyte-derived dendritic cells.

42. Complement-dependent control of teratoma formation by embryonic stem cells.

43. Z39Ig is expressed on macrophages and may mediate inflammatory reactions in arthritis and atherosclerosis.

44. First identification of a chemotactic receptor in an invertebrate species: structural and functional characterization of Ciona intestinalis C3a receptor.

45. Human mast cell-derived gelatinase B (matrix metalloproteinase-9) is regulated by inflammatory cytokines: role in cell migration.

46. Suppression of complement regulatory proteins (CRPs) exacerbates experimental autoimmune anterior uveitis (EAAU).

47. gC1qR expression in chimpanzees with resolved and chronic infection: potential role of HCV core/gC1qR-mediated T cell suppression in the outcome of HCV infection.

48. Influenza a viruses upregulate neutrophil toll-like receptor 2 expression and function.

49. Regulation of CD93 cell surface expression by protein kinase C isoenzymes.

50. Anaplasma phagocytophilum infection reduces expression of phagocytosis-related receptors on neutrophils.

Catalog

Books, media, physical & digital resources